The independent source for health policy research, polling, and news.
761 - 780 of 835 Results
Under ordinary circumstances, these phases of vaccine development can take years to complete. But now, during the age of coronavirus, the timeline is being shortened. Here's an inventory of where things stand.
A federal study finds 35% of people 60 and older were vaccinated for shingles by 2018, up from 7% in 2008, but low-income people and those who are Black or Hispanic are far less likely to get vaccinated.
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
Easy-breezy guest writer Rachel Bluth fills you in on a healthy dose of news from this past week.
The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
KHN senior correspondent Jordan Rau spins through this week’s essential health care news.
KHN executive editor Damon Darlin wades through mounds of health care policy stories — so you don’t have to.
Just about every state is lifting some coronavirus-related restrictions, but it’s unclear how things are really going, considering data on the spread of the virus lags and may not be reliable. Meanwhile, the federal government continues to throw more responsibility for dealing with the pandemic to state and local governments. Margot Sanger-Katz of The New York Times, Kimberly Leonard of Business Insider and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
Trials are an immense undertaking involving tens of thousands of participants. They’re likely to start this summer — but don’t expect quick results. And what’s a successful result, anyway?
Vaccines and antivirals have long been an afterthought but Johnson & Johnson and other firms are widely publicizing how they might stop COVID 19.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
In one conservative pocket of Montana, a local health board member who opposes vaccinations helped fight the state’s stay-at-home rules. But now, as the state slowly reopens, she faces a backlash of her own.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Activists failed to convince state legislators that diseases like measles aren’t serious enough to require vaccination. Now they’re joining with conservatives and other anti-lockdown demonstrators who contend the coronavirus isn’t dangerous enough to justify staying home.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
President Donald Trump says the country has seen a peak in new cases, but that doesn’t mean the end of the pandemic, experts say. Buckle in — we could be social distancing into 2022.
States tried to tighten vaccine requirements last year in the midst of measles outbreaks, but a backlash against a tougher law in Maine put a referendum on the ballot there. Voters weigh in on Super Tuesday.
Health care experts thought the battle was won against heart disease, measles, smoking, STDs and other life-threatening conditions and behaviors. Better think again.
© 2026 KFF